The safe and effective treatment is a proprietary patented pharmaceutical medicine-based behaviour programme pioneered by Dr David Sinclair who has already designed a similar treatment program that has shown remarkable results in the treatment of alcoholism.

Madrona Ventures Inc. (soon to be known as Lightlake Therapeutics Inc)  is a drug discovery company focusing on developing new and innovative solutions to obesity and eating disorders.

Dr Sinclair, the scientist who discovered this new approach for weight management and obesity, previously patented The Sinclair Method which is already being used by alcohol clinics. Dr Sinclair has now refined this method to provide a precise treatment of eating disorders. The program weakens and removes unhealthy eating habits while simultaneously preserving and reinforcing healthy eating behaviours, exercising, and other calorie-burning activities.

Says Dr Sinclair: “The method is unique because it doesn’t view obesity as a single monolithic disease but targets the one in three cases with a specific subtype that can be treated safely and effectively. Finding medicines that cause a loss of weight is easy. Finding one that does so safely is the hard part.”

Madrona Ventures Inc. will be starting the phase II double-blind placebo-controlled clinical trial in Finland.  The trial will last for six months.

US researchers say obesity related disease costs the US $147billion a year. In Britain, the Department of Health estimates obesity is costing the NHS £4.7billion per annum. Both countries estimate that 25% of the population is now obese and these figures are rising. The total market for weight reduction includes obesity drugs but also surgical procedures, diet programs, diet foods, exercise regimes, fitness machines, and spas.  The amount spent each year is in excess of a trillion dollars ($1,000,000,000,000), i.e., an order of magnitude higher that the most profitable blockbuster medicine.  In the UK alone, the annual cost of obesity to society is estimated at $12 billion (£7,500,000,000).

This bill would essentially require repeat drunk drivers to undergo pharmacological extinction for alcoholism, gambling, opiates, and all other endophinogenic behaviors during the period of probation. This bill’s expected effect would be to notably decrease the incidence of alcoholism and alcohol related crimes throughout the state. The total effectiveness would be dependent upon the percentage of drunk drivers who are endorphin addiction based alcoholics and how well they can ensure compliance. In the year 2000, roughly 30,000 convictions occurred for drunk driving offenses in the state of Wisconsin.

Dr. David Sinclair will present highlights from his 40+ years of research, in order to help the attendees understand the process of alcohol addiction and how Pharmacological Extinction eliminates the cravings. Dr. Roy Eskapa will share his experience and success stories from his years working the Sinclair Method with real people, and he will be there to answer your questions and help you understand how the Method works. There will also be small group study sessions and question and answer sessions to help you understand the Method, take home Support Guides and Informational Materials, Internet Access to Video Archives of the Event and a Healthy Gourmet Lunch all in beautiful Santa Barbara.

Registration for the conference can be done at http://ezregister.com/events/398/. For more information, email Kris Costello at learn@wellnesstalkradio.com or call Wellness TalkRadio at (805) 717-0795.

Dr. Marc Potenza of Yale University will be in charge of this program. He is internationally recognized for his research into the drug treatment for pathological gambling.

After this gripping opening, Ruth Pollard uses the event to discuss the current health and political concerns around the naltrexone implants. Both the safety and effectiveness of the implant remain in serious question.

The interview with Ella Glasser is particularly compelling. She’s a young lady who has recently overcome aolcoholism with the help of TSM. Ella very effectively conveys the hopelessness and dispair that alcoholics feel towards ever living a normal life, and the full experience of having your addiction extinguished via the Sinclair Method. This interview is highly recommended for anyone who is considering the Sinclair Method, or those close to someone who is trying it.

Archives of these shows will be posted after they’ve aired.

“Within three to four months of starting treatment, naltrexone, when compared with a placebo, can reduce relapse to heavy drinking 20 to 40 percent, Dr. Willenbring said. Some European practitioners claim even greater effectiveness.”

In a news release, Dr. Nicholas Grahame states that the result “strongly suggests that impulsivity contributes to high alcohol drinking”. While that conclusion could be made, the study does not established a causal link between impulsivity and drinking. This leaves the possibility that both impulsiveness and drinking stem from a common source like a stronger endorphin response.